Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Adakveo: An FDA-indicated treatment for sickle cell disease

By Brian Buntz | July 22, 2021

Adakveo NovartisAdakveo (crizanlizumab-tmca) from Novartis is FDA indicated for reducing the number of vaso-occlusive crises in people aged 16 years and older with sickle cell disease.

Novartis describes it as “the first and only once-monthly medication to reduce the number of pain crises in sickle cell disease.”

The drug works by inhibiting selectin, a group of carbohydrate-binding transmembrane molecules associated with cells clinging together, which results in vaso-occlusive crisis

Adakveo

 


Filed Under: Hematology
Tagged With: Adakveo, crizanlizumab-tmca, Novartis, sickle cell disease
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Roche in Drug Discovery & Development Pharma 50
Roche shares upbeat Phase 3 data for Hemlibra in hemophilia
Akebia/Otsuka
Akebia Therapeutics gets complete response letter from the FDA for vadadustat for CKD-associated anemia
Agios
Mitapivat from Agios scores FDA nod as for hemolytic anemia in adults
What is Human AB serum?

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50